Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Maze Therapeutics (MAZE) Revenue (2024)

Maze Therapeutics has reported Revenue over the past 1 years, most recently at $2.5 million for Q3 2024.

  • Quarterly Revenue changed N/A to $2.5 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Jun 2025, changed N/A year-over-year, with the annual reading at $167.5 million for FY2024, N/A changed from the prior year.
  • Revenue was $2.5 million for Q3 2024 at Maze Therapeutics, down from $15.0 million in the prior quarter.
  • Over five years, Revenue peaked at $15.0 million in Q2 2024 and troughed at $2.5 million in Q3 2024.